These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 23830577)

  • 41. The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
    Morales-Barrera R; Suárez C; González M; Valverde C; Serra E; Mateo J; Raventos C; Maldonado X; Morote J; Carles J
    Cancer Treat Rev; 2020 Jun; 86():102000. PubMed ID: 32203842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Raj T; Kanellakis P; Pomilio G; Jennings G; Bobik A; Agrotis A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1845-51. PubMed ID: 16709940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
    Bedussi F; Bottini A; Memo M; Fox SB; Sigala S; Generali D
    Expert Opin Ther Targets; 2014 Jun; 18(6):665-78. PubMed ID: 24833241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast growth factor signaling controlling bone formation: an update.
    Marie PJ
    Gene; 2012 Apr; 498(1):1-4. PubMed ID: 22342254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular signaling by fibroblast growth factor receptors.
    Eswarakumar VP; Lax I; Schlessinger J
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):139-49. PubMed ID: 15863030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FGF receptors: cancer biology and therapeutics.
    Katoh M; Nakagama H
    Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroblast growth factor receptor signaling crosstalk in skeletogenesis.
    Miraoui H; Marie PJ
    Sci Signal; 2010 Nov; 3(146):re9. PubMed ID: 21045207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family.
    Gavine PR; Mooney L; Kilgour E; Thomas AP; Al-Kadhimi K; Beck S; Rooney C; Coleman T; Baker D; Mellor MJ; Brooks AN; Klinowska T
    Cancer Res; 2012 Apr; 72(8):2045-56. PubMed ID: 22369928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast growth factor signaling in non-small-cell lung cancer.
    Semrad TJ; Mack PC
    Clin Lung Cancer; 2012 Mar; 13(2):90-5. PubMed ID: 21959109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
    Ye T; Wei X; Yin T; Xia Y; Li D; Shao B; Song X; He S; Luo M; Gao X; He Z; Luo C; Xiong Y; Wang N; Zeng J; Zhao L; Shen G; Xie Y; Yu L; Wei Y
    Breast Cancer Res Treat; 2014 Feb; 143(3):435-46. PubMed ID: 24398778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FGF-FGFR signaling in vertebrate organogenesis.
    Kato S; Sekine K
    Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):631-8. PubMed ID: 10512194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
    Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
    Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Roles of fibroblast growth factor receptors in carcinogenesis.
    Haugsten EM; Wiedlocha A; Olsnes S; Wesche J
    Mol Cancer Res; 2010 Nov; 8(11):1439-52. PubMed ID: 21047773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
    Marek L; Ware KE; Fritzsche A; Hercule P; Helton WR; Smith JE; McDermott LA; Coldren CD; Nemenoff RA; Merrick DT; Helfrich BA; Bunn PA; Heasley LE
    Mol Pharmacol; 2009 Jan; 75(1):196-207. PubMed ID: 18849352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Future applications of FGF/FGFR inhibitors in cancer.
    Ghedini GC; Ronca R; Presta M; Giacomini A
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotactic migration of mesencephalic neural crest cells in the mouse.
    Kubota Y; Ito K
    Dev Dyn; 2000 Feb; 217(2):170-9. PubMed ID: 10706141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors.
    Dai S; Zhou Z; Chen Z; Xu G; Chen Y
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting fibroblast growth factor receptor pathway in breast cancer.
    Criscitiello C; Esposito A; De Placido S; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):452-6. PubMed ID: 26397764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.